Renal glycosphingolipid metabolism is dysfunctional in lupus nephritis

Journal of the American Society of Nephrology

Volumn 26, Issue 6, 2015, Pages 1402-1413

  Nowling, Tamara K ^a,b   Mather, Andrew R ^c   Thiyagarajan, Thirumagal ^b   Hernández Corbacho, María José ^d   Powers, Thomas W ^b   Jones, E Ellen ^b   Snider, Ashley J ^d,e   Oates, Jim C ^a,b   Drake, Richard R ^b   Siskind, Leah J ^f  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSYLCERAMIDE; GLYCOSPHINGOLIPID; LACTOSYLCERAMIDE; LACTOSYLCERAMIDE SYNTHASE; SIALIDASE; SIALIDASE 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1A; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; NEU1 PROTEIN, MOUSE; SREBF1 PROTEIN, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNE COMPLEX DEPOSITION; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY CORTEX; KIDNEY METABOLISM; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; SPHINGOLIPID METABOLISM; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION; TISSUE LEVEL; TRANSCRIPTION REGULATION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; URINALYSIS; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; DISEASE COURSE; DISEASE MODEL; FOLLOW UP; GENETICS; IMMUNOBLOTTING; KIDNEY FUNCTION TEST; METABOLISM; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NEEDLE BIOPSY; PATHOLOGY; PATHOPHYSIOLOGY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

ANALYSIS OF VARIANCE; ANIMALS; BIOMARKERS; BIOPSY, NEEDLE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GLYCOSPHINGOLIPIDS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION TESTS; LUPUS NEPHRITIS; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; NEURAMINIDASE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; URINALYSIS;

EID: 84930431446     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014050508     Document Type: Article

References (41)

1. Manson JJ, Rahman A: Systemic lupus erythematosus. Orphanet J Rare Dis 1: 6, 2006
2. Perry ES, Davies SV, Laversuch C: Acute systemic lupus erythematosus on the acute medical take: Are we missing anything? Clin Med 11: 268-270, 2011
3. Joseph A, Brasington R, Kahl L, Ranganathan P, Cheng TP, Atkinson J: Immunologic rheumatic disorders. J Allergy Clin Immunol 125[Suppl2]: S204-S215, 2010
4. Crispín JC, Liossis SN, Kis-Toth K, Lieberman LA, Kyttaris VC, Juang YT, Tsokos GC: Pathogenesis of human systemic lupus erythematosus: Recent advances. Trends Mol Med 16: 47-57, 2010
5. Moser KL, Kelly JA, Lessard CJ, Harley JB: Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 10: 373-379, 2009
6. Tsokos GC, Wong HK, Enyedy EJ, Nambiar MP: Immune cell signaling in lupus. Curr Opin Rheumatol 12: 355-363, 2000
7. Ramanujam M, Davidson A: Targeting of the immune system in systemic lupus erythematosus. Expert Rev Mol Med 10: e2, 2008
8. Ebert EC, Hagspiel KD: Gastrointestinal and hepatic manifestations of systemic lupus erythematosus. J Clin Gastroenterol 45: 436-441, 2011
9. Isbel NM:Glomerulonephritis - management in general practice. Aust Fam Physician 34: 907-913, 2005
10. Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ: Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med148: 1198-1215, 1978
11. Mather AR, Siskind LJ: Glycosphingolipids and kidney disease. Adv Exp Med Biol 721: 121-138, 2011
12. Miyagi T, Tsuiki S: Evidence for sialidase hydrolyzing gangliosides GM2 and GM1 in rat liver plasma membrane. FEBS Lett 206: 223-228, 1986
13. Misasi R, Dionisi S, Farilla L, Carabba B, Lenti L, Di Mario U, Dotta F: Gangliosides and autoimmune diabetes. Diabetes Metab Rev 13: 163-179, 1997
14. Lacetti P, Tombaccini D, Aloj S, Grollman EF, Kohn LD: Gangliosides, the thyrotropin receptor, and autoimmune thyroid disease. Adv Exp Med Biol 174: 355-367, 1984
15. Nagai Y, Momoi T, Saito M, Mitsuzawa E, Ohtani S: Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides. Neurosci Lett 2: 107-111, 1976
16. Miyamoto K, Takada K, Furukawa K, Furukawa K, Kusunoki S: Roles of complex gangliosides in the development of experimental autoimmune encephalomyelitis. Glycobiology 18: 408-413, 2008
17. Ponzin D, Menegus AM, Kirschner G, Nunzi MG, Fiori MG, Raine CS: Effects of gangliosides on the expression of autoimmune demyelination in the peripheral nervous system. Ann Neurol 30:678-685, 1991
18. Steck AJ, Kappos L: Gangliosides and autoimmune neuropathies: Classification and clinical aspects of autoimmune neuropathies. J Neurol Neurosurg Psychiatry 57[Suppl]: 26-28, 1994
19. Willison HJ: Gangliosides as targets for autoimmune injury to the nervous system. J Neurochem 103[Suppl 1]: 143-149, 2007
20. Theofilopoulos AN, Dixon FJ: Murine models of systemic lupus erythematosus. Adv Immunol 37: 269-390, 1985
21. Rome S, Lecomte V, Meugnier E, Rieusset J, Debard C, Euthine V, Vidal H, Lefai E: Microarray analyses of SREBP-1a and SREBP-1c target genes identify new regulatory pathways in muscle. Physiol Genomics 34:327-337, 2008
22. Eberlé D, Hegarty B, Bossard P, Ferré P, Foufelle F: SREBP transcription factors: Master regulators of lipid homeostasis. Biochimie 86: 839-848, 2004
23. Wang S, Yang N, Zhang L, Huang B, Tan H, Liang Y, Li Y, Yu X: Jak/STAT signaling is involved in the inflammatory infiltration of the kidneys in MRL/lpr mice. Lupus 19: 1171-1180, 2010
24. Drappa J, Brot N, Elkon KB: The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr. Proc Natl Acad Sci U S A 90: 10340-10344, 1993
25. Nishie T, Hikimochi Y, Zama K, Fukusumi Y, Ito M, Yokoyama H, Naruse C, Ito M, Asano M: Beta4-galactosyltransferase-5 is a lactosylceramide synthase essential for mouse extra-embryonic development. Glycobiology 20: 1311-1322, 2010
26. Pérez de Lema G, Maier H, Nieto E, Vielhauer V, Luckow B, Mampaso F, Schlöndorff D: Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol 12: 1369-1382, 2001
27. Richard EM, Thiyagarajan T, Bunni MA, Basher F, Roddy PO, Siskind LJ, Nietert PJ, Nowling TK: Reducing FLI1 levels in the MRL/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolism. PLoS ONE 8: e75175, 2013
28. Puri V, Jefferson JR, Singh RD, Wheatley CL, Marks DL, Pagano RE: Sphingolipid storage induces accumulation of intracellular cholesterol by stimulating SREBP-1 cleavage. J Biol Chem 278: 20961-20970, 2003
29. Wang Z, Jiang T, Li J, Proctor G, McManaman JL, Lucia S, Chua S, Levi M: Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes 54: 2328-2335, 2005
30. Jiang T, Liebman SE, Lucia MS, Li J, Levi M: Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease. Kidney Int 68: 2608-2620, 2005
31. Sun L, Halaihel N, Zhang W, Rogers T, Levi M: Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus. J Biol Chem 277: 18919-18927, 2002
32. Oates JC, Shaftman SR, Self SE, Gilkeson GS: Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis. Arthritis Rheum 58: 263-272, 2008
33. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725, 1997
34. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH; The Committee on Prognosis Studies in SLE: Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 35: 630-640, 1992
35. Zhang XK, Gallant S, Molano I, Moussa OM, Ruiz P, Spyropoulos DD, Watson DK, Gilkeson G: Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice. J Immunol 173: 6481-6489, 2004
36. Atkinson C, Qiao F, Song H, Gilkeson GS, Tomlinson S: Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice. J Immunol 180: 1231-1238, 2008
37. Bielawski J, Szulc ZM, Hannun YA, Bielawska A: Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods 39: 82-91, 2006
38. Bielawski J, Pierce JS, Snider J, Rembiesa B, Szulc ZM, Bielawska A: Comprehensive quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods Mol Biol 579: 443-467, 2009
39. Nowling TK, Fulton JD, Chike-Harris K, Gilkeson GS: Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes. Mol Immunol 45: 1-12, 2008
40. Jones EE, Powers TW, Neely BA, Cazares LH, Troyer DA, Parker AS, Drake RR: MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma. Proteomics 14: 924-935, 2014
41. Jones EE, Dworski S, Canals D, Casas J, Fabrias G, Schoenling D, Levade T, Denlinger C, Hannun YA, Medin JA, Drake RR: On-tissue localization of ceramides and other sphingolipids by MALDI mass spectrometry imaging. Anal Chem 86: 8303-8311, 2014